Prospect CapitalProAssurance

Prospect Capital vs ProAssurance

Private lender funding US middle market businesses vs US medical malpractice insurer for doctors and hospitals. Which is the better buy for your portfolio in June 2026? Plain-English answer below.

Prospect Capital deploys capital as a business-development company hunting yield in middle-market credit, while ProAssurance writes specialty liability insurance and sits on the other side of risk ent...

Investment Analysis

Pros

  • Prospect Capital has strategically shifted to first lien senior secured middle market loans, increasing their first lien mix to 71.1%, reducing risk exposure.
  • The company surpassed EPS expectations in Q1 2025 with $0.17 reported versus $0.11 forecasted, demonstrating strong profitability in the quarter.
  • Consistent monthly shareholder distributions enhance investor confidence, supporting stable income even amid revenue fluctuations.

Considerations

  • Annual revenue is declining, with a 16.51% drop reported in fiscal 2025 compared to previous periods, indicating challenges in growth.
  • Despite quarterly EPS beats, the company reported a negative basic EPS of -$1.35 over the last twelve months, reflecting ongoing profitability issues.
  • The top-line investment income missed analyst revenue estimates in Q1 2025, signaling potential headwinds in revenue generation.

Pros

  • ProAssurance is a leading specialty insurer with strong market positioning in healthcare professional liability and related insurance sectors.
  • The company holds an excellent A.M. Best rating, reflecting financial strength and reliability in insurance underwriting.
  • Diverse product offerings across medical professional, product liability, legal professional liability, and workers’ compensation enhance risk diversification.

Considerations

  • ProAssurance operates in highly regulated and competitive insurance markets, exposing it to regulatory and pricing pressure risks.
  • The company’s financial performance is sensitive to claims volatility inherent to professional liability insurance.
  • Dependence on healthcare and life sciences sectors may limit growth if these industries face downturns or regulatory changes.

Buy PSEC or PRA in Nemo

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Frequently asked questions

PSEC
PSEC$2.48
vs
PRA
PRA$24.29
Buy PRA